Search Results 151-160 of 15748 for alt

1. A Study to Compare High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy - Mayo Clinic

   ALT > 500 U/L;; Bilirubin > 12 mg/dL. Previous enrollment in this study. Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

2. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 2.5 × ULN;; Bilirubin ≤ 1.5 × ULN - unless considered due to leukemic organ involvement. Women of child-bearing potential ...

3. Vitamins and supplements for fatty liver disease (MASLD) - Mayo Clinic

   Research suggests that in people who have MASLD, vitamin E may boost the liver's natural antioxidants, help reduce liver inflammation and scarring, and help ...

4. A Study Of IMO-2125 In Combination With Ipilimumab Versus Ipilimumab Alone In Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   Aspartate aminotransferase (AST) ≤ 2.5 x ULN; alanine aminotransferase (ALT) ≤ 2.5 x ULN; AST/ALT < 5 x ULN if liver involvement (≤ Grade 1);; Serum ...

5. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Alanine transaminase (ALT) >1.5x Upper Limit of Normal (ULN). Total bilirubin >1.5xULN; Participants with Gilbert's syndrome can be included with total ...

6. Alisertib In Treating Patients With Myelofibrosis Or Relapsed Or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   ... (ALT) =< 2.5 x ULN; AMKL PATIENTS: Creatinine < 1.5 x ULN or calculated creatinine clearance > 30 ml/min; AMKL PATIENTS: Prothrombin time (PT) and partial ...

7. A Study Of Donor-Alloantigen-Reactive Regulatory T Cell Therapy With An Immunosuppression Regimen In Adult Liver Transplantation - Mayo Clinic

   Alanine Aminotransferase (ALT) >2.0 x upper limit of normal (ULN). Inability to taper off corticosteroids by 44 days (+/- 2 days) after transplant ...

8. A Global, Randomized, Placebo-controlled Phase 3 Study Of Fruquintinib In Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   ... ALT are eligible. Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 2.5 × ULN in patients without hepatic metastases; ALT or AST >5 × ULN ...

9. A Study To Compare Three Chemotherapy Regimens For The Treatment Of Patients With Newly- Diagnosed Mantle Cell Lymphoma - Mayo Clinic

   ... ALT requirements: AST/ALT ≤ 5 x institutional ULN. Prothrombin time (PT)/international normalized ratio (INR) or partial thromboplastin time (aPTT) in the ...

10. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...